Inhibitor

Loading results

In the News

powered by Ovast
  • Roche Terminates Development Of CETP Inhibitor Dalcetrapib - Forbes

    google.com 3 weeks, 2 days ago

    Bloomberg Roche Terminates Development Of CETP Inhibitor Dalcetrapib Forbes Roche announced today that it had ended development of dalcetrapib, its entry in the once-promising class of HDL-raising CETP inhibitors. A data and safety monitoring board recommended that the dal-OUTCOMES phase 3 trial be stopped due to a lack of ... Roche Abandons Cholesterol Drug Trial On Poor Results Roche Drops After Halting Cholesterol Drug Development Roche abandons potential blockbuster cholesterol drug

  • Roche Terminates Development Of CETP Inhibitor Dalcetrapib

    forbes.com 3 weeks, 2 days ago

    Roche announced today that it had ended development of dalcetrapib, its entry in the once-promising class of HDL-raising CETP inhibitors. A data and safety monitoring board recommended that the dal-OUTCOMES phase 3 trial be stopped due to a lack of clinically meaningful efficacy. The DSMB found no evidence of safety problems. Here is the press ...

Photos

powered by
Loading photos for 'Inhibitor'

On Twitter

Loading tweets for 'Inhibitor'

Videos

Additional Info

via Wikipedia
Loading info for 'Inhibitor'
Loading recipes for 'Inhibitor'

Weather -

Loading weather for 'Inhibitor'

Web Search Results

powered by
Loading web results for 'Inhibitor'
Loading More Stories